Explore more publications!

Press Releases

Xi and Macron have friendly exchanges in China’s Chengdu
J-POWER: Redefining Home Fitness with Patented Power and Global Ambition
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
China Airlines Launches Non-Stop Flights Between Taipei and Phoenix
Sega Sammy Sets the Stage in Tokyo for the Cybersecurity Woman of Japan Awards 2025
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
Healthtech Market Is Booming Worldwide With Boston Scientific, Philips Healthcare, Abbott Laboratories, Medtronic
India Medical Devices Market Predicted to Flourish at 7.4% CAGR, Surpassing USD 78.35 Billion by 2035
Global Times: China-France relations in next 60 years carry greater expectations"
From WHO to Om: Dr. Gururaj Mutalik's 'Visions of Yoga' Charts a Research-Based Path to Healthy Aging
Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
Fitness Apps to Reach $120.37 Billion by 2030 on Rising Wellness Trends and Smartphone Use
Global Times: Relic from Emperor Qinshihuang’s Kunlun quest highlights China’s pluralistic yet unified civilization
Sales Order Processing Automation Strengthens Supply Chain Efficiency Across U.S. Hospitals
Sales Order Processing Automation Revolutionizes U.S. Healthcare Workflows
Apeiron Therapeutics Presents First-in-Human Data from Phase 1 Clinical Trial of GTA182 in MTAP-Deleted Advanced Non-Small Cell Lung Cancer at the ESMO Asia Congress 2025
Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions